Table 5.

Relative risks (RRs) with 95% confidence intervals (CIs) for ID versus gPop stratified by sex and diagnoses of COPD and asthma.

Drug		Men	Women
COPD	At least one R03	0.97 (0.85–1.11)	0.95 (0.88–1.04)
	R03A: Adrenergics, inhalants	1.03 (0.87–1.21)	0.91 (0.78–1.05)
	R03BA: Glucocorticoids	1.09 (0.75–1.58)	0.83 (0.54–1.26)
	R03BB: Anticholinergics	0.81 (0.62–1.05)	0.88 (0.69–1.14)
	R03C: Adrenergics for systemic use a		21.58 (2.86–163)
	R03D: Other systemic drugs	0.80 (0.36–1.74)	2.29 (0.81–6.47)
Asthma	At least one R03	0.99 (0.93–1.05)	0.95 (0.90–1.00)
	R03A: Adrenergics, inhalants	0.92 (0.83–1.01)	0.88 (0.82–0.95)
	R03BA: Glucocorticoids	0.88 (0.71–1.10)	0.91 (0.73–1.12)
	R03BB: Anticholinergics	1.06 (0.62–1.81)	0.45 (0.26–0.78)
	R03C: Adrenergics for systemic use	9.28 (3.40–25.4)	38.0 (5.30–272)
	R03D: Other systemic drugs	1.21 (0.68–2.16)	1.36 (0.80–2.29)

^a: Not assessed for men due to low numbers of prescriptions.